By Colin Kellaher Nektar Therapeutics on Thursday said it would regain full rights to rezpegaldesleukin from partner Eli Lilly & Co., which is ending...
Topline Big-tech stocks rallied after earnings this week and drove big gains for major indexes, but the number of stocks actually outperforming the broader...
A complex scenario has been brewing which makes the presidential race completely unpredictable, just like the near future of the country. It is probably...
The US House Financial Services Committee and House Agriculture Committee are set to introduce comprehensive legislation to oversee the cryptocurrency sector in the next...